RNA - Avidity Biosciences, Inc.

QQQ $ 635.83 $ 0.00 (0 %)

DIA $ 475.37 $ 0.00 (0 %)

SPY $ 686.97 $ 0.00 (0 %)

TLT $ 90.89 $ 0.00 (0 %)

GLD $ 365.33 $ 0.00 (0 %)

Previous Close

$ 69.65

Open

$ 69.93

Bid

$ 69.00 x 77

Ask

$ 69.69 x 10

Day's Range

-- - --

52 Week Range

$ 21.51 - $ 70.51

Volume

25,128,359

Average Volume

Market Cap

8.96B

Beta (5Y Monthly)

$ 1.27

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-07-2025	06-30-2025	10-Q
2	05-08-2025	03-31-2025	10-Q
3	02-27-2025	01-01-1970	10-K
4	11-07-2024	09-30-2024	10-Q
5	08-09-2024	06-30-2024	10-Q
6	05-09-2024	03-31-2024	10-Q
7	02-28-2024	12-31-2023	10-K
8	11-08-2023	09-30-2023	10-Q
9	08-08-2023	06-30-2023	10-Q
10	05-09-2023	03-31-2023	10-Q
11	02-28-2023	12-31-2022	10-K
12	11-08-2022	09-30-2022	10-Q
13	08-09-2022	06-30-2022	10-Q
14	05-10-2022	03-31-2022	10-Q
15	03-01-2022	12-31-2021	10-K
16	11-09-2021	09-30-2021	10-Q
17	08-09-2021	06-30-2021	10-Q
18	05-12-2021	03-31-2021	10-Q
19	03-15-2021	12-31-2020	10-K
20	11-10-2020	09-30-2020	10-Q
21	08-11-2020	06-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

$1000 Invested In Avidity Biosciences 5 Ye...
10/29/2025 20:45:35

TD Cowen Downgrades Avidity Biosciences to...
10/29/2025 13:03:20

TD Cowen analyst Ritu Baral downgrades Avidity Biosciences (NASDAQ:RNA) from Buy to Hold and lowers the price target from $7...

nucor-to-rally-more-than-14-here-are-10-top-analyst-forecasts-for-tuesday

Nucor To Rally More Than 14%? Here Are 10 ...
10/28/2025 11:48:22

this-boot-barn-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-tuesday

This Boot Barn Analyst Is No Longer Bullis...
10/28/2025 11:23:50

Chardan Capital Downgrades Avidity Bioscie...
10/28/2025 11:16:10

Chardan Capital analyst Keay Nakae downgrades Avidity Biosciences (NASDAQ:RNA) from Buy to Neutral and lowers the price targ...

novartis-maintains-outlook-even-as-generics-bite-into-profits

Novartis Maintains Outlook Even As Generic...
10/28/2025 10:58:47

Novartis Q3 sales rose 8% to $13.91 billion, missing estimates, as Kisqali and Kesimpta drove growth while U.S. generics weighe...

RBC Capital Downgrades Avidity Biosciences...
10/28/2025 10:18:34

RBC Capital analyst Luca Issi downgrades Avidity Biosciences (NASDAQ:RNA) from Outperform to Sector Perform and raises the p...

merger-monday-makes-comeback-as-us-ma-tops-80-billion-in-24-hours

'Merger Monday' Makes Comeback As US M&A T...
10/28/2025 09:44:49

U.S. companies have struck more than $80 billion worth of deals in the past 24 hours, in the latest sign that mergers and acqui...

avidity-biosciences-soars-after-72-per-share-novartis-takeover

Avidity Biosciences Soars After $72 Per Sh...
10/27/2025 18:52:41

Avidity Biosciences (RNA) to be acquired by Novartis in a $12 billion cash deal. H.C. Wainwright downgrades to Neutral.

12 Health Care Stocks Moving In Monday's I...
10/27/2025 17:05:57

Citigroup Downgrades Avidity Biosciences t...
10/27/2025 16:43:39

Citigroup analyst Geoff Meacham downgrades Avidity Biosciences (NASDAQ:RNA) from Buy to Neutral and lowers the price target ...

Raymond James Downgrades Avidity Bioscienc...
10/27/2025 15:22:24

Raymond James analyst Martin Auster downgrades Avidity Biosciences (NASDAQ:RNA) from Strong Buy to Market Perform.

janus-henderson-avidity-biosciences-bridgebio-pharma-and-other-big-stocks-moving-higher-on-monday

Janus Henderson, Avidity Biosciences, Brid...
10/27/2025 14:21:30

12 Health Care Stocks Moving In Monday's P...
10/27/2025 12:06:22

booking-holdings-to-rally-around-12-here-are-10-top-analyst-forecasts-for-monday

Booking Holdings To Rally Around 12%? Here...
10/27/2025 12:00:54

this-harley-davidson-analyst-turns-bearish-here-are-top-5-downgrades-for-monday

This Harley-Davidson Analyst Turns Bearish...
10/27/2025 11:45:23

Bernstein Downgrades Avidity Biosciences t...
10/27/2025 11:39:09

Bernstein analyst William Pickering downgrades Avidity Biosciences (NASDAQ:RNA) from Outperform to Market Perform and raises...

Needham Downgrades Avidity Biosciences to ...
10/27/2025 11:29:35

Needham analyst Joseph Stringer downgrades Avidity Biosciences (NASDAQ:RNA) from Buy to Hold and maintains the price target ...

HC Wainwright & Co. Downgrades Avidity Bio...
10/27/2025 10:44:58

HC Wainwright & Co. analyst Ananda Ghosh downgrades Avidity Biosciences (NASDAQ:RNA) from Buy to Neutral and lowers the ...

avidity-shareholders-win-big-as-novartis-moves-fast-on-12-billion-deal

Avidity Shareholders Win Big As Novartis M...
10/27/2025 10:11:40

Avidity Biosciences (NASDAQ: RNA) shares soar as Novartis (NYSE: NVS) agrees to acquire them for $12 billion in cash.